Literature DB >> 8153310

Chronic diffuse infiltrative lung disease: determination of the diagnostic value of clinical data, chest radiography, and CT and Bayesian analysis.

P Grenier1, S Chevret, C Beigelman, M W Brauner, C Chastang, D Valeyre.   

Abstract

PURPOSE: To assess the value of clinical, chest radiographic, and computed tomographic (CT) findings in classifying chronic diffuse infiltrative lung disease (CDILD)
MATERIALS AND METHODS: Two samples from the same population were consecutively studied: the training set (group A, n = 208) for the development of the decision aid and the test set (group B, n = 100) for validation. Computer-aided diagnoses were made with a Bayesian model that assigned to each patient diagnostic probabilities based on clinical, radiographic, or CT variables.
RESULTS: In group A, a correct diagnosis based on clinical data was obtained in 29% of cases; radiography, 9%; and CT, 36%. This increased to 54% when clinical and radiographic variables were combined (P < .0001) and to 80% when data from all three were analyzed together (P < .0001). With prior and conditional probabilities determined from group A, the frequency of correct diagnosis in group B was 27% with clinical data, which increased to 53% (P < .0001) with radiographic findings and 61% after including CT data (P = .07).
CONCLUSION: CT can help determine the specific diagnosis in patients with CDILD.

Entities:  

Mesh:

Year:  1994        PMID: 8153310     DOI: 10.1148/radiology.191.2.8153310

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

Review 1.  Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis.

Authors:  A Wells
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

Review 2.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

Review 3.  [Diagnostic imaging of pulmonary lymphangiosis carcinomatosis].

Authors:  B Rehbock; H-G Hieckel
Journal:  Radiologe       Date:  2004-05       Impact factor: 0.635

4.  The clinical impact of high resolution computed tomography in patients with respiratory disease.

Authors:  Nicholas J Screaton; Fiona N A C Miller; Bipen D Patel; Ashley Groves; Angela D Tasker; David A Lomas; Christopher D R Flower
Journal:  Eur Radiol       Date:  2010-08-24       Impact factor: 5.315

5.  Pulmonary involvement in ankylosing spondylitis.

Authors:  Percival D Sampaio-Barros; Elza Maria F P Cerqueira; Sílvio M Rezende; Lucimara Maeda; Roseneide A Conde; Verônica A Zanardi; Manoel Barros Bértolo; José Ribeiro de Menezes Neto; Adil M Samara
Journal:  Clin Rheumatol       Date:  2006-03-30       Impact factor: 2.980

6.  The value of thoracic computed tomography scans in clinical diagnosis: a prospective study.

Authors:  Mark O Turner; John R Mayo; Nestor L Müller; Michael Schulzer; J Mark FitzGerald
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

7.  A Rare Case of Progressive Dyspnea and Bilateral Lung Infiltration in a Young Male.

Authors:  Meltem Ağca; Fatma Tokgöz Akyıl; Merve Hörmet; Oğuzhan Akman; Canan Akman; Ayçim Şen; Tülin Sevim
Journal:  Turk Thorac J       Date:  2017-07-01

8.  Strategies for medical data extraction and presentation part 1: current limitations and deficiencies.

Authors:  Bruce Reiner
Journal:  J Digit Imaging       Date:  2015-04       Impact factor: 4.056

9.  High-resolution computed tomography to differentiate chronic diffuse interstitial lung diseases with predominant ground-glass pattern using logical analysis of data.

Authors:  Sophie Grivaud Martin; Louis-Philippe Kronek; Dominique Valeyre; Nadia Brauner; Pierre-Yves Brillet; Hilario Nunes; Michel W Brauner; Frédérique Réty
Journal:  Eur Radiol       Date:  2009-12-08       Impact factor: 5.315

Review 10.  Imaging aspects of the diagnosis of sarcoidosis.

Authors:  Paolo Spagnolo; Nicola Sverzellati; Athol U Wells; David M Hansell
Journal:  Eur Radiol       Date:  2014-01-08       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.